Product

Portfolio Intelligence Portside Congress trades Super-investors Economic calendar Earnings calendar Pricing

Company

About FAQs Contact Create account

Legal

Privacy Terms Portside rules

APUS stock Smart Money — Apimeds Pharmaceuticals US, Inc. filings, insiders & smart money · Instaport

APUS

Apimeds Pharmaceuticals US, Inc.

COMMON STOCK · NYSE AMERICAN

Price and daily changeSign in

Earnings11 Nov 2026

52-week rangeSign inDay rangeSign in

Market cap: Sign in
Volume: Sign in
Beta: Sign in
Shares float: Sign in
Short interest: 1.32%
P/E (fwd): Sign in
PEG (fwd): Sign in

Price chart (1D to 10Y)

Licensed market data — shown to members, not published to the open web.

Create free account

Overview Statistics Statements Dividends🔒Momentum🔒Quant🔒Fair Value🔒Earnings Analysts🔒Insiders Smart Money Options🔒Insights🔒

Super Investors

SEC Form 13F · quarter ended 30 Jun 2026

None of the tracked super-investors reported APUS last quarter.

Congress

House & Senate disclosures

No member of Congress has disclosed a APUS position.

A snapshot of reported ownership. Congress reports value ranges; Super Investors report quarterly 13F positions. Dates differ and positions may have changed since filing.

See the full stock page

Prices, charts, ranges, valuation ratios, dividends, momentum and analyst estimates are licensed for signed-in members. A free account opens every stock, fund and crypto page.

Create free account

Source: SEC filings. Information and analytics, not investment advice.

Loading evidence for APUS

Rev growth (fwd)